期刊文献+

巨噬细胞在脓毒症中的免疫调节作用研究进展 被引量:4

Research progress in immunoregulatory role of macrophages in sepsis
原文传递
导出
摘要 巨噬细胞作为脓毒症中天然免疫反应中的抗感染细胞及特异性免疫中的关键抗原呈递细胞,其功能变化在脓毒症中的作用受到人们的特别关注。该文综述了巨噬细胞在脓毒症中的免疫调节作用研究进展。 Macrophages are anti-infected cells in the innate immune response in sepsis,and are critical antigen-presenting cells in specific immune.So their changes of function in sepsis are of particular concern.This paper reviews the immunoregulatory function changes of the macrophages in sepsis.
出处 《军事医学》 CAS CSCD 北大核心 2013年第6期469-471,共3页 Military Medical Sciences
基金 国家自然科学基金资助项目(81072475) 国家973计划资助项目(2007CB512406)
关键词 脓毒症 巨噬细胞 免疫调节 sepsis macrophage immune regulation
  • 相关文献

参考文献19

  • 1Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, et al. The pathogenesis of sepsis [ J ]. Annu Rev Pathol,2011,6 : 19 - 48.
  • 2Ward PA. Immunosuppression in sepsis[J]. JAMA, 2011, 306 (23) :2618 -2619.
  • 3Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003 [J]. Crit Care Med, 2007, 35(5):1244-1250.
  • 4Hotchkiss RS, Donald DW. Apoptosis and caspases regulate death and inflammation in sepsis[ J]. Nat Rev Immunol, 2006, 6 (11) :813 -822.
  • 5Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas[J]. J Clin Invest,2012, 122(3) :787 -795.
  • 6Nemeth K, Leelahavanichkul A, Yuen PS3", et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin- 10 production [ J ]. Nat Med, 2008, 15 ( 1 ) :42 - 49.
  • 7Adib-Conquy M, Cavaillon JM. Stress molecules in sepsis and systemic inflammatory response syndrome[ J ]. FEBS Lett, 2007, 581 ( 19 ) :3723 - 3733.
  • 8Hotchkiss RS, Opal S. Immunotherapy for sepsis--a new approach against an ancient foe[ J]. N Engl J Med, 2010, 363 (1) :87 -89.
  • 9Schwandt T, Schumak B, Gielen GH, et al. Expression of type I interferon by splenic maerophages suppresses adaptive immu- nity during sepsis[ J]. EMBO J, 2011,31 ( 1 ) :201 -213.
  • 10Faivre V, Lukaszewicz AC, Alves A, et al. Accelerated in vitro differentiation of blood monocytes into dendritic cells in human sepsis [ J ]. Clin Exp Immuno1,2007, 147 ( 3 ) :426 - 439.

同被引文献59

  • 1刘晓蓉,任新生.脓毒症凝血机制及组织因子通路抑制剂治疗的研究现状及治疗进展[J].中国急救医学,2005,25(11):833-835. 被引量:19
  • 2魏芳,王立华,姜埃利.脓毒血症与内皮细胞功能异常[J].国际移植与血液净化杂志,2006,4(5):9-12. 被引量:2
  • 3吴健,李澎,陈卫民.血清C反应蛋白水平预测危重症患者预后的临床研究[J].中国医科大学学报,2007,36(3):358-358. 被引量:11
  • 4吴盂超,吴在德.黄家驷外科学[M].7版.北京:人民卫生出版社,2008:1768-1777.
  • 5Cheng BL’Xie GH,Yao SL,et al. Epidemiology of severesepsis in critical ill surgical patients in ten university hos-pitals in China [J]. Crit Care Med,2007,35 ( 11 ) : 2538-2546.
  • 6Dellinger RP’Levy MM,Rhodes A,et al. Surviving sepsiscampaign: International guidelines for management of se-vere sepsis and septic shock: 2012 [J]. Crit Care Med,2013,41:580-637.
  • 7Dinarello CA. Proinflammatory cytokines [J]. Chest, 2000,118(2);503-508.
  • 8Heper Y, Akalin EH,Mistik R,et al. Evaluation of serumC-reactive protein, procalcitonin, tumor necrosis factor al-pha, and interleukin-10 levels as diagnostic and p- rognos-tic parameters in patients with community-acquired sep-sis, severe sepsis,and septic shock[J]. Eur J Clin Microbi-ol Infect Dis,2006,25(8) :481-491.
  • 9Takahashi N, Hasegawa H, Komiyama M, et al. Electiveexcretion of anti-inflammatory cytokine interleukin-10 in asuperantigen-inducing neonatal infectious disease [J]. Cy-tokine, 2009 ,45(1) : 39-43.
  • 10Santana Reyes C,Garcia-Muoz F.Reyes D, et al. Role ofcytokines (interleukin-1 beta,6,8,tumor necrosis factor-a, and soluble receptor of interleukin-2) and C-reactiveprotein in the diagnosis of neonatal sepsis[J], Acta Paedi-atr,2003,92(3):221-227.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部